INVITAE GOOD OPPORTUNITY Invitae offers gene panels and single-gene testing for a broad range of clinical areas including hereditary cancer, cardiology, neurology, pediatric genetics, metabolic disorders, immunology, and hematology.
The price is on a strong weekly pattern, decent long opportunity on probable bullish rebound.
Medical
NGENF Nervgen Consolidation continues Possible entry aheadNice long ~2 year consolidation is in progress, recent reject from the top side of wedge will present entry opportunities
Entry target ~ 1.15-1.35 (1.25 average)
Interesting medical treatments currently in trials
Long term play
MIRO Miromatrix Medical Price TargetMiromatrix Medical Inc. engages in the development of biological human organs to solve the chronic shortage of transplantable organs.
114,000 people in the U.S. are waiting for a life-saving organ transplant, and more than half will die due to a lack of available organs.
Miromatrix Medical trial is expected to begin in the second half of 2022 and will assess the function of a bioengineered liver in humans via an external application.
if it succeeds, the opportunity to buy the stock at these prices will be history.
The Market Cap of MIRO is just 214.74Mil
On 7/19/2021 Craig Hallum brokerage Initiated Coverage with a Buy rating and a $22.00 price target
BNGO do you still love me???Does BNGO still loves us? Why doesnt it just says so?!?
Should we simply ask? Or wait it to show us?
Omg what to do....
I think it really does love us! Just be confident in yourselfs and be patient!
Ontrak seems not to want to forget the prices of the pastThe company Ontrak has always proved to be an excellent partner for care centers, unfortunately in recent months one of their major customers has decided to abandon the contract with the company Ontrak.
This has led to a rapid decline in prices, but the company is proving to have a good basis to start again, the technology they produce is essentially unique and at the top of the category.
Currently Ontrak comes defined 'heavy undervalued' in the sites of reference that I use for the fundamental analysis that is the price of the action turns out to be 85.4% under to the just value.
Maybe that’s why many big investors are coming back to invest in Ontrak, I find the indicator Miracle Viewer that detects the flows of money categorizing them by type of players.
And that’s why the Market miracle advisor gave an input signal on Ontrak at the price of 31.19 usd and a target of 35.98 usd or with a possible profit of 15.37%
Analyzing the diagram is clear as it is drawing a reversal to U slightly in climb that testifies the strong pressure of purchase on the Stock.
Looking at the cyclical nature of the big players I expect that in the coming weeks or at most within the next month the purchase pressure increases further, so I venture to make a further forecast for a second possible target.
This idea is based on the signal generated by the Marketmiracle advisor whose link you can find by scrolling at the bottom of this page.
Opportunity for Bullish Trend CTIIn a recent days I was looking into CTI's price movement. It's very interesting, if you look at candlestick performance, candlestick patterns e t.c. And today I'm looking on a big zone of interest for trading. As you can see, spike in volume like this means it's going to go up very shortly. My recommendation would be to buy at the lowest in this zone, which you can do right now, set up some s/l and then expect profit around 20% in a day or two. Or you could buy this as an long-term investment into medical sphere. Which expected to grow further along as more and more spheres goes into crypto. It will be growing on a daily basis, but right now it's more of an insight. So if you are looking into year or so investment - explore this project for yourself a little more, it's a good skill to learn early and a perfect opportunity to start lays before you.
Medical investing opportunity CTIAs one of my hobbies is thinking about different spheres of possible crypto-influence, i am always looking into something new. For example, medicine in which data science has taken it's toll. One of project like this, which I found on twitter, was ClinTex. One of strategies for investing is to diverse your funds and think about net-profit which it wil give you in a year or two. These guys are a good possible investment from the getgo. I layed for you some foundation which you could use in your short-time trending with some interesting analysis of future growth and points of entry into this sphere. Enjoy!
SNDL update!SNDL in his way to the target. It may takes time. remember there is no stock that go straight up. (((patience)))!
$RAD At an important area of contention$RAD At an important area of contention. I'll be watching closely for a break above. I'm liking the setup if it can close above resistance.
Scenario 2 is more realistic!SNDL is maybe going to touch a new support line! Im thinking its more realistic for sndl to touch 0.6$ and then take off huge!
Trading Idea - #Fresenius SEBUY
ENTRY: 40.85 EUR
TARGET: 50.00 EUR (+22%)
STOP: 37.00 EUR
1.) Fresenius is breaking out of the POC box (Point of Control/Point of Interest). Technicall, an upward movement is expected.
2.) 42.80 EUR level needs to fall, so that an attack on the mid-term resistance (44.00 EUR) can occure.
3.) Fresenius works intensively at the cost reduction, which should make the company more profitable.
THYROCARE recently turned trend, about to test resistance zone.Hi. In this 1D chart I've plotted a few things: the recent MA 56 crossing that marked a trend turn, the approaching resistance zone from November last year and an interpretation of the movements since then as Elliott Waves.
You can also see:
There is still rooms for the Williams 224 to climb further.
The historical volatility is lower than it was in November indicating a more stable trend.
The Ichimoku is agreeing with the recent trend turn.
There is possibility that the MACD will turn down across its signal but I believe that it will either skirt the signal and then continue rising or pass below it momentarily as the current Elliott Correction Wave plays out.
It should be noted that the fundamentals of THYROCARE are absolutely excellent and therefore could be worth holding not only for the immediate future.
Thank you. Please if you have any thoughts or comments do leave them below and I would gladly discuss or adjust my interpretations and methods.
This does not constitute financial advice.
Any prices, even if explicitly stated, are presented with intent to discuss the symbol and potential interpretations.
Any trades shown or mentioned are examples and neither recommendations or mandates.
HAPP just finished Elliott Correction Wave, Impulse incoming?Hi. In this 1D chart I've plotted the Elliott Wave patterns from the latest months and from it concluded that the next wave will be an impulse wave, as a clear correction wave has just finished.
The size of the incoming impulse is of course subject to speculation, but the certainty of it is substantial according to my analys of the latest patterns.
Thank you. Please if you have any thoughts or comments do leave them below and I would gladly discuss or adjust my interpretations and methods.
This does not constitute financial advice.
Any prices, even if explicitly stated, are presented with intent to discuss the symbol and potential interpretations.
Any trades shown or mentioned are examples and neither recommendations or mandates .
GBCS - US Based - NET PROFIT penny Stock - The KingThey focus in real estate investment and medical service
Growing fast
MMED ready for a trip higherThe flat volume should be increasing any day, for better or worse. I'm thinking for better. It has built strong support on the 100 day, & RSI is trending up while price is riding an upward trend line. It looks decent, and now is a good time for a lot of stocks to break out of their slumps.
I'm noticing numerous stocks at a tipping point so I think Monday or Tuesday should bring large movements to confirm bullish or bearish breakouts in the market.
INVO Potential Day TradeINVO potential day trade. I may enter above the 5.85 for a price target of 7.45 on a bounce up from support. It appears that volume is concentrated at two primary levels, this trade attempts to profit on that spread.
(Just an idea, not advice)
EARS Long Swing-Trade IdeaThe rising reverse wedge pattern highlights common lower support and higher resistance trend.
A pattern has emerged where the price appears to spike on/around the 9th and 21st of the month and the price seems to rise up to the next level of the fibonacci retracement (Support/Resistance).
I would consider taking a long position at the $3.50 level for a potential move up to $6.00 by 22/Mar/2021.
The fibonacci retracement levels are derived from a previous high volume price spike event that occurred on 1/Dec/2020 wherein the highest concentration of volume occurred at the $5.14 - 5.61 price range.
It is probable that a high number of investors are locked in within that price range and may induce more sellers at these levels, thus there will be significant resistance to pass through that price range on the next spike. $6.00 is possible, but $5.50 may be a more realistic price target due to resistance.
I currently have no position in EARS, so this is just my unbiased opinion based on previous stock performance.
APHA Day Trade IdeaAPHA (Aphria, Inc.) is rebounding up from a support line on the year to date rising fibonacci channel.
It is probable that APHA will continue it's upward momentum up to 17.81 for an approximate 13% gain (+/-) upon where it would encounter the yearly 61.8% fibonacci resistance level.
If APHA crosses above 17.81, the Point of control (POC) where volume is most concentrated is at 18.75.
Crossing this level is less probable but not impossible, as APHA has been known to out perform both in market hours and after hours.
I currently have no position in APHA, so this is just my unbiased opinion.
ZOMZomedica looks like it will be a winner once its veterinarian office lab testing product launches on March 30 . ZOM stock is already up 850% so far this year. In fact, it peaked at $2.70 in early February in anticipation of this product launch.Moreover, the company has very smart about taking advantage of its huge price spike. On Feb. 8, it raised another $185.4 million. In fact, as of Feb. 26, Zomedica had an astounding $277.5 million in cash on its balance sheet, based on an 8-K filing
SENS Breakout Price Targets and ResistancesSENS still has some room to run. The price targets are based off of the extended support and resistances of the run up to previous all time highs.
Pull backs within the up trend can be expected to retrace to underlying lines drawn when price moves above.
